MedTrace Logo

Evaluation of APAP With SensAwake in OSA and Insomnia Patients

NCT02721329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2020-07-02

No results posted yet for this study

Summary

The hypothesis is that APAP with SensAwake improves wake-after sleep onset compared to APAP without SensAwake in a patient population with Obstructive Sleep Apnea Syndrome (OSAS) and Insomnia.

Conditions

Interventions

DEVICE

APAP

Automatic Continuous Positive Airway Pressure

DEVICE

APAP with SensAwake

Automatic Continuous Positive Airway Pressure with SensAwake enabled. SensAwake is a pressure relief technology that detects the transition from sleep to wake, and promptly reduces the pressure during wakeful periods.

Sponsors & Collaborators

  • University Hospital, Grenoble

    collaborator OTHER

  • University Hospital, Angers

    collaborator OTHER_GOV

  • Fisher and Paykel Healthcare

    lead INDUSTRY

Principal Investigators

  • Jean-Louis Pepin, MD · CHU du Grenoble

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02721329 on ClinicalTrials.gov